- ML-18
-
- $30.00
-
2026-05-11
- CAS:1422269-30-4
- Purity: 98.62%
- Supply Ability: 10g
|
| Product Name: | ML 18 | | Synonyms: | ML 18;BRS-3 antagonist;ML18;ML-18;ML 18;BRS-3 ANTAGONIST;1422269-30-4;ML18, >98%;(2S)-3-(1H-INDOL-3-YL)-N-{[1-(4-METHOXYPHENYL)CYCLOHEXYL]METHYL}-2-{[(4-NITROPHENYL)CARBAMOYL]AMINO}PROPANAMIDE;(S)-3-(1H-Indol-3-yl)-N-((1-(4-methoxyphenyl)cyclohexyl)methyl)-2-(3-(4-nitrophenyl)ureido)propanamide;Bombesin Receptor,ML-18,ML 18,inhibit,Inhibitor,ML18;ML-18, 10 mM in DMSO | | CAS: | 1422269-30-4 | | MF: | C32H35N5O5 | | MW: | 569.66 | | EINECS: | | | Product Categories: | | | Mol File: | 1422269-30-4.mol |  |
| | ML 18 Chemical Properties |
| Boiling point | 821.8±65.0 °C(Predicted) | | density | 1.291±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO: soluble | | form | A solid | | pka | 11.99±0.46(Predicted) | | color | White to yellow |
| | ML 18 Usage And Synthesis |
| Description | ML-18 is a non-peptide bombesin receptor subtype 3 (BB3) antagonist that inhibits [125I]BA1 binding to NCI-H1299 lung cancer cells transfected with human BB3 receptors (IC50 = 4.8 μM). It is selective for BB3 over the gastrin releasing peptide receptor (GRPR) and the neuromedin B receptor (NMBR) with IC50 values of 16 and >100 μM, respectively, in a radioligand binding assay. ML-18 (16 μM) reversibly inhibits BA1-induced increases in cytosolic calcium in NCI-H1299 cells. It also inhibits BA1-induced phosphorylation of ERK and EGFR and reduces proliferation of NCI-H1299 cells. | | Uses | ML-18 is a non-peptide bombesin receptor subtype-3 antagonist. It also inhibits lung cancer growth. | | References | [1] TERRY W. MOODY . ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth[J]. Peptides, 2015, 64: Pages 55-61. DOI: 10.1016/j.peptides.2014.12.005 |
| | ML 18 Preparation Products And Raw materials |
|